Maltose
- Generic Name
- Maltose
- Drug Type
- Small Molecule
- Chemical Formula
- C12H22O11
- CAS Number
- 69-79-4
- Unique Ingredient Identifier
- 66Y63L379N
- Background
A dextrodisaccharide from malt and starch. It is used as a sweetening agent and fermentable intermediate in brewing (Grant & Hackh's Chemical Dictionary, 5th ed).
- Associated Conditions
- Iron Deficiency Anemia (IDA)
Probiotics for Quality of Life in Autism Spectrum Disorders
Early Phase 1
Completed
- Conditions
- Autism Spectrum DisordersAnxiety
- Interventions
- Drug: Visbiome Extra Strength
- First Posted Date
- 2016-09-16
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Ohio State University
- Target Recruit Count
- 13
- Registration Number
- NCT02903030
- Locations
- 🇺🇸
Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Trehalose as add-on Therapy in Bipolar Depression
Phase 3
Completed
- Conditions
- Bipolar DepressionBipolar Disorder
- Interventions
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Consorcio Centro de Investigación Biomédica en Red (CIBER)
- Target Recruit Count
- 60
- Registration Number
- NCT02800161
- Locations
- 🇪🇸
Hospital Clinic of Barcelona, Barcelona, Spain
Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors
Phase 1
Suspended
- Conditions
- TumorsNeoplasmsCancer
- Interventions
- First Posted Date
- 2012-03-26
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Anaeropharma Science, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT01562626
- Locations
- 🇺🇸
MD Anderson, Houston, Texas, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath